Anti-her3 / muc1 antibodies and uses thereof

EP4683648A4Pending Publication Date: 2026-06-17XADCERA BIOPHARMACEUTICAL (SUZHOU) CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
XADCERA BIOPHARMACEUTICAL (SUZHOU) CO LTD
Filing Date
2024-02-06
Publication Date
2026-06-17

Smart Images

  • Figure CN2024076272_26092024_PF_FP
    Figure CN2024076272_26092024_PF_FP
Patent Text Reader

Abstract

This disclosure relates to anti-HER3 / MUC1 antibodies, and antibody drug conjugates derived therefrom, and the use thereof.
Need to check novelty before this filing date? Find Prior Art